Abstract
Unsustainable health costs impose a new health care paradigm, where the support to clinical decision making assumes a critical importance. In this context, several machine learning risk assessment models have been developed in order to support a proper patients’ stratification. Although their superior performances, machine learning-based risk assessment models have faced strong difficulties to obtain the trust of professionals in their application in daily clinical practice. This work proposes a strategy able to address some of the major limitations of such models: i) interpretability; ii) personalization; iii) ability to incorporate new knowledge/new risk factors.
An hybrid scheme is developed, combining knowledge-driven methods (to create an interpretable set of rules for the general population) with data-driven methods (to select the most suitable subset of rules for each individual). Three main steps can be identified: i) derivation of an initial set of rules directly from current clinical evidence and/or data, ii) personalized scheme where a subset of the initial rules is identified as the most adequate one to classify a given patient; iii) an ensemble voting strategy based on the outputs of the previously selected rules. Moreover, the strategy demonstrates a high flexibility to incorporate new risk factors (in this case the inflammation biomarker), through the definition of additional rules.
This strategy was applied in the context of cardiovascular disease, namely on the risk stratification of Acute Coronary Syndromes patients. It was validated based on a real dataset composed of N = 1544 patients, admitted in the Cardiology Unit of Coimbra Hospital and Universitary Centre, achieving a SE = 0.763 and SP = 0.778.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collins, G., Moons, K.: Reporting of artificial intelligence prediction models. Lancet 393(10181), 1577–1579 (2019). https://doi.org/10.1016/S0140-6736(19)30037-6
Visseren, F., et al.: ESC scientific document group, 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42(34), 3227–3337 (2021). https://doi.org/10.1093/eurheartj/ehab484
Lai, H., et al.: Predictive models for diabetes mellitus using machine learning techniques. BMC Endocr. Disord. 19, 101 (2019). https://doi.org/10.1186/s12902-019-0436-6
Kourou, K., et al.: Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J. 13, 8–17 (2015). https://doi.org/10.1016/j.csbj.2014.11.005
Krittanawong, C., et al.: Machine learning prediction in cardiovascular diseases: a meta-analysis. Sci. Rep. 10, 16057 (2020). https://doi.org/10.1038/s41598-020-72685
Goodman, B., Flaxman, S.: European union regulations on algorithmic decision-making and a “Right to Explanation.” AI Mag. 38(3), 50–57 (2017). https://doi.org/10.1609/aimag.v38i3.2741
Timmis, A., et al.: ESC scientific document group. European society of cardiology: cardiovascular disease statistics 2017. Eur. Heart J. 39(7), 508–579 (2018). https://doi.org/10.1093/eurheartj/ehx628. PMID: 29190377
Tscherny, K., et al.: Risk stratification in acute coronary syndrome: evaluation of the GRACE and CRUSADE scores in the setting of a tertiary care centre. Int. J. Clin. Pract. 74(2), e13444 (2020). https://doi.org/10.1111/ijcp.13444
Fioranelli, M., et al.: Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front. Immunol. (2018). https://doi.org/10.3389/fimmu.2018.02031
Valente, F., et al.: Interpretability, personalization and reliability of a machine learning based clinical decision support system. Data Min. Knowl. Disc. 36, 1140–1173 (2022). https://doi.org/10.1007/s10618-022-00821-8
Doshi-Velez, F., Kim, B.: Towards a rigorous science of interpretable machine learning. arXiv: arXiv:1702.08608 (2017)
Acknowledgments
This work is funded by the FCT - Foundation for Science and Technology, I.P./MCTES through national funds (PIDDAC), within the scope of CISUC R&D Unit - UIDB/00326/2020 or project code UIDP/00326/2020.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Paredes, S., Rocha, T., de Carvalho, P., Roseiro, I., Henriques, J., Sousa, J. (2024). Cardiovascular Risk Assessment: An Interpretable Machine Learning Approach. In: Pino, E., Magjarević, R., de Carvalho, P. (eds) International Conference on Biomedical and Health Informatics 2022. ICBHI 2022. IFMBE Proceedings, vol 108. Springer, Cham. https://doi.org/10.1007/978-3-031-59216-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-031-59216-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-59215-7
Online ISBN: 978-3-031-59216-4
eBook Packages: EngineeringEngineering (R0)